Friday, May 13, 2016

Mylan to buy Renaissance's topical business for $950 mln

May 13 (Reuters) - Drugmaker Mylan NV said it would

buy Renaissance Acquisition Holdings LLC's non-sterile,

topicals-focused specialty and generics business for $950

million.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)